Caregiver‐reported symptom burden and preferences for therapeutic goals in pediatric primary sclerosing cholangitis
Journal of Pediatric Gastroenterology and Nutrition · 2024
DOI: 10.1002/jpn3.12287 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2024. Verfasst von Holly Payton Shifman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Caregivers, Quality of Life, Cost of Illness. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, Bill Falik UCSF PSC Research Program, NIDDK NIH HHS.
Abstract (Originalsprache)
This study analyzed qualitative and quantitative survey responses from 51 pediatric primary sclerosing cholangitis (PSC) patients and caregivers using the PSC Partners Patient Registry– Our Voices survey. The most common symptoms reported by children/caregivers include: fatigue (71%), abdominal pain (69%), anxiety (59%), appetite loss (51%), insomnia (49%), and pruritus (45%). When experiencing symptoms at their worst, over half of patients/caregivers reported limitations in physically demanding activities (67%), work/school duties (63%), social life activities (55%), and activities for fun or exercise (53%). Over half of patients/caregivers expressed willingness to participate in clinical trials, however none reported ever participating in trials for new or investigational PSC drugs. This study revealed a substantial patient/caregiver‐reported symptom burden for children with PSC that impacts quality of life and limits access to clinical trials. Future efforts should focus on developing patient‐centered clinical endpoints for PSC trials, increasing trial availability for pediatric PSC patients, and reducing logistical barriers to trial involvement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Pediatrics, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts, USA.
- PSC Partners Seeking a Cure, Greenwood Village, Colorado, USA.
- Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
- Department of Pediatrics, University of California, San Francisco, San Francisco, California, USA.
ORCID-Profile: Holly Payton Shifman, Sharad I Wadhwani
Förderung
- NIA NIH HHS
- Bill Falik UCSF PSC Research Program
- NIDDK NIH HHS
- University of California, San Francisco (UCSF) Liver Center
Zitieren
APA
Shifman, H. P., Hatchett, J., Pai, R. A., Safer, R., Gomel, R., Vyas, M., Li, M., Lai, J. C., & Wadhwani, S. I. (2024). Caregiver‐reported symptom burden and preferences for therapeutic goals in pediatric primary sclerosing cholangitis. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.12287
Vancouver
Shifman HP, Hatchett J, Pai RA, Safer R, Gomel R, Vyas M, et al. Caregiver‐reported symptom burden and preferences for therapeutic goals in pediatric primary sclerosing cholangitis. Journal of Pediatric Gastroenterology and Nutrition. 2024. doi:10.1002/jpn3.12287
BibTeX
@article{Shifman2024,
author = {Shifman, Holly Payton and Hatchett, Joanne and Pai, Ruth-Anne and Safer, Ricky and Gomel, Rachel and Vyas, Mary and Li, Michael and Lai, Jennifer C and Wadhwani, Sharad I},
title = {Caregiver‐reported symptom burden and preferences for therapeutic goals in pediatric primary sclerosing cholangitis},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2024},
doi = {10.1002/jpn3.12287}
}
EUVIMED